Breast cancer is a heterogeneous malignancy that can be divided into several molecular subtypes according to estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor 2 (HER2). This evidence concerns the gene ERBB2 and breast carcinoma.